- This event has passed.
Future Directions in Neuroscience
May 27 @ 12:00 pm - 1:15 pm
Carlos Brody, Wilbur H. Gantz III ’59 Professor of Neuroscience
Sanders (Sandy) Williams ’70, Professor of Medicine, Duke University and UCSF
Seemant Chaturvedi ’85, Greenebaum Endowed Professor of Stroke Neurology, Univ. of Maryland School of Medicine
Jordan Amadio ’05, Neurosurgeon, University of Texas Seton Medical Center, Austin, Texas
Meredith Bock ’10, Neurology Resident Physician, University of California, San Francisco
Wilbur H. Gantz III ’59 Professor of Neuroscience
Carlos Brody is professor of neuroscience and molecular biology at Princeton University and a Howard Hughes Medical Institute Investigator. He completed his Ph.D. in 1997, in computation and neural systems with John Hopfield at the California Institute of Technology. Starting in 2001, he led a computational neuroscience group as an assistant professor at Cold Spring Harbor Laboratory. Inspired by the efforts that Zachary Mainen’s and Anthony Zador’s experimental groups at Cold Spring Harbor Laboratory were making in developing highly controlled behaviors for rats, Brody added experimental approaches to his research portfolio. His focus is on novel quantitative behaviors that allow exploring high-level cognitive questions using powerful emerging tools for studying neural mechanisms in rats. Brody’s group now uses rats to investigate the neural bases of decision making, working memory and executive control using a combination of high-throughput semiautomated behavior as well as computational, electrophysiological, pharmacological and optogenetic methods. Brody moved to Princeton University in 2006, and has been a Howard Hughes Medical Institute Investigator since 2008.
Sanders (Sandy) Williams ’70
Professor of Medicine, Duke University and UCSF
R. Sanders (Sandy) Williams, MD, is a physician-scientist and biomedical executive. He is President Emeritus of the Gladstone Institutes in San Francisco. Currently he serves as Professor of Medicine and Senior Advisor for Science and Technology at Duke University, as well as Professor of Medicine at UCSF. His previous positions include: Dean of the School of Medicine at Duke University, founding Dean of the Duke-NUS Graduate Medical School in Singapore and Chief of Cardiology at the University of Texas Southwestern Medical Center. He was educated at Princeton University and Duke School of Medicine, and pursued advanced training in science and medicine at Harvard (residency at Massachusetts General Hospital), Duke (cardiology and biochemistry fellowships), Oxford University (molecular biology) and Cold Spring Harbor Laboratory (molecular biology). He is active at the interface between academia and life science industries, serving currently as a Director of public companies Amgen and Laboratory Corporation of America, and of private early-stage biotechnology companies E-scape Bio and Tenaya Therapeutics. He served previously as a Director of Bristol-Myers Squibb. Dr. Williams is a member of the U.S. National Academy of Medicine.
Seemant Chaturvedi ’85
Greenebaum Endowed Professor of Stroke Neurology, Univ. of Maryland School of Medicine
Seemant Chaturvedi, MD, is the Stewart J, Greenebaum Endowed Professor of Stroke Neurology at the University of Maryland School of Medicine. He also serves as Stroke Program Director at the University of Maryland Medical System and Vice-Chair for Strategic Operations in the Department of Neurology. After graduating from Princeton University in 1985, Dr. Chaturvedi completed his neurology residency at the University of Massachusetts Medical Center and a stroke fellowship at the University of Western Ontario. Dr. Chaturvedi has co-edited two books, “Transient Ischemic Attacks” (2004) and “Carotid Artery Stenosis” (2005). Dr. Chaturvedi led the carotid surgery guidelines committee for the American Academy of Neurology.
He has been involved with several guideline writing committees for the American Academy of Neurology and American Stroke Association and is on the steering committee of several clinical trials. Dr. Chaturvedi’s research interests include carotid and intracranial atherosclerosis, gender differences in stroke and stroke in young adults.
Dr. Chaturvedi has been listed in Best Doctors in America for over 20 consecutive years and he has been interviewed by numerous organizations, including the New York Times, for opinions pertaining to neurology/stroke. He has previously served as President of the Princeton Club of Michigan (2006-2014) and President of the Association of Indian Neurologists in America (2017-2019). Twitter: @Chaturvedineuro
Jordan Amadio ’05
Neurosurgeon, University of Texas Seton Medical Center, Austin, Texas
Dr. Jordan Amadio ’05 , MD is an attending neurosurgeon at the University of Texas Dell Seton Medical Center in Austin, TX. He is also the founder of NeuroLaunch, the first neuroscience startup incubator.
Dr. Amadio completed a degree in biophysics at Princeton University and earned his M.D. degree from Harvard Medical School. He was among the first cohort of physicians to earn a concurrent MBA from Harvard Business School. He completed a 7-year residency in neurosurgery at Emory University, where he served as Chief Resident in 2016.
Dr. Amadio’s research interests include medical technology innovation, surgical robotics, and neuro-ethics.
His writing and expert commentary has been featured by publications such as The Associated Press, The Independent, Natural History, Cell, Nature Publishing Group, and the BBC. In 2014, Dr. Amadio was one of 15 young physicians to receive the American Medical Association Foundation’s Excellence in Medicine Award. He has been an invited speaker at numerous conferences and institutions, including Genentech, Harvard University, Georgia Tech, Mayo Clinic, TEDx, SXSW, and Exponential Medicine.
Meredith Bock ’10
Neurology Resident Physician, University of California, San Francisco
Meredith Bock ’10 began her career in medicine with a Princeton Alumnicorps fellowship at the University of California, San Francisco (UCSF) Breast Care Center, where she first developed a passion for the combination of patient-centered care and clinical research. She stayed at UCSF for medical school and completed the Clinical and Translational Research Pathway. She received an MD with Distinction for her research on cognitive screening in patients with amyotrophic lateral sclerosis. Meredith continued at UCSF for Neurology residency and further training in clinical research, now focusing on the epidemiology of dementia and cognitive syndromes in patients with Parkinson’s disease. Outside of work, she is an avid runner, new dog mom and enthusiastic participant in regular in person (and now virtual) reunions with her Princeton 2010 community.